Letko, Brosseau & Associates Inc Pfizer Inc Transaction History

Letko, Brosseau & Associates Inc

$5.65 Billion
Q1 2024

A detailed history of Letko, Brosseau & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 3,129,098 shares of PFE stock, worth $87.6 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares

3,129,098

Previous 3,048,168 2.66%

Holding current value

$87.6 Million

Previous $87.8 Million 1.05%

% of portfolio

1.54%

Previous 1.63%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $2.1 Million - $2.41 Million	80,930 Added 2.66%	3,129,098 $86.8 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $24.5 Million - $31.9 Million	938,933 Added 44.52%	3,048,168 $87.8 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $1.09 Million - $1.27 Million	33,990 Added 1.64%	2,109,235 $70 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $15.2 Million - $17.5 Million	419,502 Added 25.34%	2,075,245 $76.1 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $519,554 - $676,383	13,190 Added 0.8%	1,655,743 $67.6 Million

Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $1.16 Million - $1.51 Million	-27,722 Reduced 1.66%	1,642,553 $84.2 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $4.62 Million - $5.64 Million	-105,533 Reduced 5.94%	1,670,275 $73.1 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $7.5 Million - $8.89 Million	-161,175 Reduced 8.32%	1,775,808 $93.1 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $4.69 Million - $5.81 Million	-102,480 Reduced 5.02%	1,936,983 $100 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $2.91 Million - $4.31 Million	-70,315 Reduced 3.33%	2,039,463 $120 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $5.84 Million - $7.51 Million	-148,905 Reduced 6.59%	2,109,778 $90.7 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $28.5 Million - $32.3 Million	794,122 Added 54.22%	2,258,683 $88.5 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $1.32 Million - $1.49 Million	-39,375 Reduced 2.62%	1,464,561 $53.1 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $5.2 Million - $6.61 Million	-155,410 Reduced 9.37%	1,503,936 $55.4 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $5.46 Million - $6.4 Million	-171,847 Reduced 9.38%	1,659,346 $60.9 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $3.09 Million - $3.75 Million	-102,630 Reduced 5.31%	1,831,193 $59.9 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $137,853 - $196,962	5,100 Added 0.26%	1,933,823 $63.1 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $2.37 Million - $2.69 Million	-72,040 Reduced 3.6%	1,928,723 $75.6 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $2.19 Million - $2.84 Million	-67,296 Reduced 3.25%	2,000,763 $71.9 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $5.12 Million - $5.75 Million	-138,390 Reduced 6.27%	2,068,059 $89.6 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $4.65 Million - $5.11 Million	-123,942 Reduced 5.32%	2,206,449 $93.7 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $21.6 Million - $24.6 Million	-560,256 Reduced 19.38%	2,330,391 $102 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $25.9 Million - $31.4 Million	-751,627 Reduced 20.64%	2,890,647 $127 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $2.89 Million - $3.08 Million	-87,610 Reduced 2.35%	3,642,274 $132 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $4.77 Million - $5.53 Million	-149,380 Reduced 3.85%	3,729,884 $132 Million
Q4 2017 Feb 20, 2018	SELL	$33.26 - $35.29 $6.13 Million - $6.5 Million	-184,243 Reduced 4.53%	3,879,264 $141 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $126 Million - $139 Million	4,063,507	4,063,507 $145 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Account

Letko, Brosseau & Associates Inc Pfizer Inc Transaction History